Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1131343 · FYE Jun 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $4.44Day −2.74%1Y −16.9%Off 52W high −24.6%Vol (1Y) 63.7%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,292 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover2.1d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)AUD 8.1M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (AUD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+44.2% |
| 1Y−16.9% |
| 3Y+53.1% |
| 5Y−67.1% |
| 10Y−90.3% |
| Since incept. (ann.)−12.4% |
Total return through 2026-07-29 · series begins 2005-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)63.7% |
| Ann. volatility (3Y)126.6% |
| Sharpe (1Y)−0.05 |
| Sharpe (3Y)0.58 |
| Max drawdown (1Y)−47.7% |
| Max drawdown (3Y)−75.0% |
| Beta (3Y vs SPY)0.13 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Twin Lakes Capital Management, LLC | 139,258 | $484,618 | 0.00% | +0.0% |
| HB Wealth Management, LLC | 58,460 | $203,441 | 0.00% | +0.0% |
| MORGAN STANLEY | 58,382 | $203,170 | 0.00% | −8.3% |
| GREENLEAF TRUST | 32,000 | $111,360 | 0.00% | +0.0% |
| CITADEL ADVISORS LLC | 20,077 | $71,474 | 0.00% | +19.4% |
| BNP PARIBAS FINANCIAL MARKETS | 6,809 | $23,695 | 0.00% | −1.4% |
| RHUMBLINE ADVISERS | 1,970 | $7,010 | 0.00% | −7.4% |
| GAMMA Investing LLC | 1,856 | $6,459 | 0.00% | +134.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for ATHE.
